Jazz Pharmaceuticals (JAZZ) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.54% |
| Dec 31, 2025 | 5.64% |
| Sep 30, 2025 | 12.32% |
| Jun 30, 2025 | 8.64% |
| Mar 31, 2025 | 21.56% |
| Dec 31, 2024 | 30.51% |
| Sep 30, 2024 | 22.77% |
| Jun 30, 2024 | 16.28% |
| Mar 31, 2024 | 21.40% |
| Dec 31, 2023 | 37.22% |
| Sep 30, 2023 | 21.76% |
| Jun 30, 2023 | 21.46% |
| Mar 31, 2023 | 20.85% |
| Dec 31, 2022 | 17.96% |
| Sep 30, 2022 | 27.14% |
| Jun 30, 2022 | 24.35% |
| Mar 31, 2022 | 7.18% |
| Dec 31, 2021 | 10.08% |
| Sep 30, 2021 | 12.88% |
| Jun 30, 2021 | 0.53% |
| Mar 31, 2021 | 16.44% |
| Dec 31, 2020 | 1.36% |
| Sep 30, 2020 | -5.77% |
| Jun 30, 2020 | -3.13% |
| Mar 31, 2020 | -2.16% |
| Dec 31, 2019 | -1.40% |
| Sep 30, 2019 | 6.70% |
| Jun 30, 2019 | 18.91% |
| Mar 31, 2019 | 17.36% |
| Dec 31, 2018 | -13.42% |
| Sep 30, 2018 | -3.24% |
| Jun 30, 2018 | -0.77% |
| Mar 31, 2018 | 0.12% |
| Dec 31, 2017 | -0.06% |
| Sep 30, 2017 | 5.89% |
| Jun 30, 2017 | 9.13% |
| Mar 31, 2017 | 15.25% |
| Dec 31, 2016 | 34.85% |
| Sep 30, 2016 | 29.35% |
| Jun 30, 2016 | 53.34% |
| Mar 31, 2016 | 72.01% |
| Dec 31, 2015 | 85.68% |
| Sep 30, 2015 | 112.87% |
| Jun 30, 2015 | 149.28% |